Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

In This Article:

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.

While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.

Why Investors Should Pay Attention to This Value Stock

Value investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, and Price/Cash Flow, the Value Style Score identifies the most attractive and most discounted stocks.

Ensign Group (ENSG)

Founded in 1999 and headquartered in San Juan Capistrano, CA, The Ensign Group Inc. provides health care services in the post-acute care continuum, urgent care center and mobile ancillary businesses in the United States.

ENSG sits at a Zacks Rank #2 (Buy), holds a Value Style Score of B, and has a VGM Score of A. Compared to the Medical - Nursing Homes industry's P/E of 21.9X, shares of Ensign Group are trading at a forward P/E of 21.9X. ENSG also has a PEG Ratio of 1.5, a Price/Cash Flow ratio of 23.2X, and a Price/Sales ratio of 1.9X.

A company's earnings performance is important for value investors as well. For fiscal 2024, one analyst revised their earnings estimate higher in the last 60 days for ENSG, while the Zacks Consensus Estimate has increased $0.01 to $5.49 per share. ENSG also holds an average earnings surprise of 1.3%.

With strong valuation and earnings metrics, a good Zacks Rank, and top-tier Value and VGM Style Scores, investors should strongly think about adding ENSG to their portfolios.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Ensign Group, Inc. (ENSG) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research